We have located links that may give you full text access.
Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi.
British Journal of Dermatology 2020 Februrary
Congenital melanocytic naevi (CMNs, commonly known as "moles") are made up of pigment cells which contain a gene that has undergone an alteration (mutation). We know that different moles have different genetic mutations (or "genotypes"), and also that different moles look and behave differently, that is they have different "phenotypes". Very rarely a CMN can be linked with problems in the brain or can even develop into a malignant tumour (melanoma). These researchers in London reviewed 156 CMNs from 134 children to see whether specific genotypes cause particular phenotypes. These children tended to have a more serious phenotype: 76% had two or more CMNs at birth, most had large CMNs, eight had malignant melanoma and 29% had an abnormality on their brain MRI scan. Regarding genotype, 68% of moles had a mutation in the NRAS gene, 7% in the BRAF gene and 25% in neither. Where two different moles were studied from the same patient, they had the same genotype. The study did not show any relationship between genotype and either malignancy or neurological problems. However, larger moles usually had mutations in NRAS while lumpy moles occurred mostly with BRAF mutations and not with NRAS. Examination of lumpy moles under the microscope showed that the lumps were composed not of CMN cells but of fat and connective tissue with the CMN tissue stretched over the top. The authors conclude that genetic testing of moles is unnecessary although it has proved useful in malignant melanoma where genotype can guide treatment options. This summary relates to the study: Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi.
Full text links
Related Resources
Trending Papers
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app